CERB: Will the Delta Variant Revive This Program?

A CRB extension could be on the cards, given the rise of the Delta variant. But Topicus.com (TSXV:TOI) could help you right away.

| More on:
Coronavirus written newspaper close up shot to the text.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The Canada Emergency Response Benefit (CERB) was an immensely popular program that helped millions of Canadian families survive last year’s crisis. The program has now been closed and replaced with a Canada Recovery Benefit (CRB) and enhanced Employment Insurance programs. 

However, the Delta variant of the COVID-19 virus complicates the global economic outlook. Cases have rebounded sharply in the U.K. and United States. Medical experts expect a similar wave in Canada. The prospect of another wave has already dented consumer confidence and spending. Will that compel the government to offer a CRB extension?

Here’s a closer look. 

CRB extension prospects

As the name suggests, CERB was designed to deal with last year’s “emergency.” It’s safe to assume the program won’t be revived because we know how to deal with this crisis better. 

That being said, the CRB and EI enhancements are temporary and are set to expire in September. These measures were meant to support the “recovery,” which has now been delayed because of the Delta variant. It’s also worth noting that Canadians are heading to the polls next month. A Liberal majority in this election could make a CRB extension much more likely. 

What we know for sure is that consumer spending, employment, and incomes haven’t fully recovered yet. Canada’s vaccination drive has been impressive, but we’re far from herd immunity. Meanwhile, a global slowdown drags our economy too. Ending benefits in September could be a misstep. 

Protect yourself

There’s no way to predict the outcome of the next election and whether the next administration will extend CRB. However, you could consider creating your own safety net before the economy or political climate changes. 

The best way to do so would be to invest in a robust growth stock that’s untethered to the local economy. Topicus.com (TSXV:TOI) is an excellent example. 

There are three reasons Topicus is an excellent pick for investors seeking stable growth in the near term. Firstly, it’s a niche software conglomerate, which means it earns recurring income from subscriptions on a wide pool of software tools. Secondly, it’s focused on Europe. European software startups are fairly valued, and the economy is detached from Canada. 

Finally, Topicus is undervalued and outperforming the rest of the stock market. The stock is up 88% ever since it went public in February this year. Over the same period, the Canadian stock market has delivered a total return of 16.4%. So, Topicus is delivering better growth. 

Put another way, $500 invested in Topicus earlier this year would be worth $940 today. That’s nearly three weeks of benefit payments. If the investment is made in a Tax-Free Savings Account (TFSA), you even avoid the tax liability of CRB. 

Bottom line

The CERB and CRB programs have helped millions of Canadians throughout this crisis. Unfortunately, it seems the crisis isn’t over yet. The economic recovery is faltering. An upcoming election could give the administration more power to implement a CRB extension. 

However, Canadians shouldn’t wait for an uncertain future. Instead, bet on robust growth stocks that can help you create a safety net.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Topicus.Com Inc. Fool contributor Vishesh Raisinghani owns shares of Topicus.Com. 

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »